MOVE vs TMO · rev $80.0K vs P/E 24, rev $44.56B
Movano Inc (MOVE) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Movano Inc (MOVE) is a software - infrastructure company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported MOVE revenue for 2025-09-30 was $80.0K. Net income was -$4.0M. Revenue was down 22.3% from 2025-06-30 to 2025-09-30. MOVE currently screens at market cap $46.1M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
MOVE currently screens at market cap $46.1M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the MOVE and TMO stock pages for the full models.
Not investment advice.